Detection and treatment of CD30+ cancers
Grant
US12590968B2
Kind: B2
Mar 31, 2026
Assignee
SEAGEN INC.
Inventors
Tina Albertson, Maria L. Smith
Abstract
The application provides methods of diagnosis, prognosis, prophylaxis and treatment of CD30+ cancers.
CPC Classifications
A61K 47/6849
C07K 16/2878
A61P 35/00
Filing Date
2022-05-18
Application No.
17747591
Claims
4